Latest Research involving 4,000 women diagnosed with breast cancer showed that aspirin consumption is proven to increase patient survival and reduce recurrence.

“About 50 percent of women with breast cancer who take aspirin, less likely to die than those not taking them,” said lead researcher Dr. Michelle Holmes, who is also professor of epidemiology at Harvard Medical School and School of Public Health, Boston, United States, such as reported by HealthDay. This research is published online on February 16 and in the Journal of Clinical Oncology.

In general, bright Holmes, for women who consumed more aspirin a week will have a higher life expectancy. This is done by comparing the aspirin users and who do not. For instance recovering patients who take aspirin for 6-7 days a week, they will have a 64 percent reduction in risk of death. 

Meanwhile, those who took aspirin for 2-5 days a week, with a variety of different reasons-even would have reduced the risk of death up to 71 percent. However, the most important is the data 50 percent of the overall risk reduction. This study did not include the dose taken, but the only time in a week usage.

The aspirin consumption also able reduces breast cancer. “Even surprise, this is a strong effect of aspirin,” said Holmes. Although he admitted this was only the study by way of observation, not a definitive determination of cause and effect.